-The Hindu JENVAC is the first vaccine to be manufactured in the public-private partnership mode India on Friday launched its first indigenous vaccine to protect children from Japanese encephalitis. Until now, the country has been importing the vaccine from China. The Vero cell-derived purified inactivated JE vaccine-JENVAC, which received manufacturing and marketing approvals from the Drug Controller General of India, is the first vaccine to be manufactured in the public-private partnership mode between...
More »SEARCH RESULT
Total Matching Records found : 114
Empty panic over iron pills-Shonali Ghosal
-Tehelka.com The media went on a overdrive and misreported facts. Hundreds of children fell sick in the last two weeks in Haryana, Delhi and Maharashtra after consuming iron and folic acid supplements given to them under under state sponsored programmes to combat anemia. Though the authorities later clarified that mild side-effects like abdominal pain and nausea were expected - there are few takers for this explanation, especially in the backdrop of the...
More »Spectre of drug shortage over TB treatment -Rupali Mukherjee
-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...
More »We trust indian manufacturing norms: USFDA -Divya Rajagopal
-The Economic Times MUMBAI: The United States Food and Drug Administration (USFDA), widely considered the world's most stringent regulatory authority, has said India's share in generic exports to the US over the years is an indication of the good manufacturing norms practised by Indian drugmakers. As the Ranbaxy scandal threatens to tarnish India's image as a hub of manufacturing world-class generic drugs, the statement, by USFDA's spokesman Chris Kelly in an...
More »Cancer medication as low as Rs 1,000/month on way -Malathy Iyer
-The Times of India MUMBAI: It's widely known that a month's dose of cancer drugs can cost lakhs, but what isn't common knowledge is that Tata Memorial Hospital's doctors are working on alternatives that could cost less than Rs 1,000 a month. Dubbed the metronomic treatment protocol, it comprises daily consumption of a combination of low-dose medicines that are cheap because they have been around for decades. "There is no need to...
More »
